Refine Results
  1. "Nai-Kong Cheung"
Formats
  1. Journal Article (349)
  2. Meeting Abstract (158)
  3. Conference Paper (11)
  4. Book Section (8)
  5. Book Whole (1)
Groups
  1. Neuroblastoma Service (527)
  2. Pediatrics, Department of (527)
  3. Neuro-Oncology Service (149)
  4. Center for Hematologic Malignancies (129)
  5. Pediatric Leukemia (107)
  6. Radiology, Department of (106)

More Groups

People
  1. Nai-Kong Cheung (527)
  2. Brian Kushner (193)
  3. Kim Kramer (147)
  4. Shakeel Modak (136)
  5. Irene Cheung (76)
  6. Steven Larson (75)

More People

Years
  1. 2020 (3)
  2. 2019 (25)
  3. 2018 (28)
  4. 2017 (25)
  5. 2016 (17)
  6. 2015 (25)

More Years

Publications
  1. Journal of Clinical Oncology (63)
  2. Pediatric Blood and Cancer (53)
  3. Cancer Research (31)
  4. Clinical Cancer Research (21)
  5. Neuro-Oncology (21)
  6. Cancer (20)

More Publications

Publishers
  1. American Association for Cancer Research (80)
  2. American Society of Clinical Oncology (63)
  3. Wiley Periodicals, Inc (56)
  4. Elsevier Inc. (32)
  5. Oxford University Press (25)
  6. Wiley Blackwell (23)

More Publishers

Results (527)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies
    Journal Article

    Santich, B. H.; Park, J. A.; Tran, H.; Guo, H. F.; Huse, M.; Cheung, N. K. V.
    Science Translational Medicine (2020)

    Fulltext@MSK | Save
  • An N-acetylgalactosamino dendron-clearing agent for high-therapeutic-index DOTA-hapten pretargeted radioimmunotherapy
    Journal Article

    Cheal, S. M.; Patel, M.; Yang, G.; Veach, D.; Xu, H.; Guo, H. F.; Zanzonico, P. B.; Axworthy, D. B.; Cheung, N. K. V.; Ouerfelli, O.; more...
    Bioconjugate Chemistry (2020)

    Fulltext@MSK | Save
  • Immunotherapy of pediatric solid tumors: Treatments at a crossroads, with an emphasis on antibodies
    Journal Article

    Casey, D. L.; Cheung, N. K. V.
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • Neuroblastoma: Pathology and genetics
    Book Section

    Cheung, N. K. V.; Lopez-Rodrigo, E.; Boffetta, P.; Hainaut, P.
    In Boffetta, P.; Hainaut, P. (Eds.) Encyclopedia of Cancer. 3rd ed (2019)

    Fulltext@MSK | Save
  • Biodistribution and dosimetry of intraventricularly administered (124)I-omburtamab in patients with metastatic leptomeningeal tumors
    Journal Article

    Pandit-Taskar, N.; Zanzonico, P. B.; Kramer, K.; Grkovski, M.; Fung, E. K.; Shi, W.; Zhang, Z.; Lyashchenko, S. K.; Fung, A. M.; Pentlow, K. S.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Silencing Fc domains in T cell-engaging bispecific antibodies improves t-cell trafficking and antitumor potency
    Journal Article

    Wang, L.; Hoseini, S. S.; Xu, H.; Ponomarev, V.; Cheung, N. K.
    Cancer Immunology Research (2019)

    Fulltext@MSK | Save
  • ATRX in-frame fusion neuroblastoma is sensitive to EZH2 inhibition via modulation of neuronal gene signatures
    Journal Article

    Qadeer, Z. A.; Valle-Garcia, D.; Hasson, D.; Sun, Z.; Cook, A.; Nguyen, C.; Soriano, A.; Ma, A.; Griffiths, L. M.; Zeineldin, M.; more...
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • Safety and efficacy of intraventricular 131I-labeled monoclonal antibody 8H9 targeting the surface glycoprotein B7-H3
    Meeting Abstract

    Kramer, K.; Pandit-Taskar, N.; Donzelli, M.; Suzanne, W.; Zanzonico, P.; Humm, J.; Haque, S.; Souweidane, M.; Greenfield, J.; Carrasquillo, J.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for high-risk neuroblastoma: Efficacy against histologically-evident primary refractory metastases in bone marrow
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save